Company profile for Inceptor Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment. To achieve this goal, we assembled a purpose-driven team, recruiting pioneers in oncology, gene therapy, cell therapy and gene editing to join our mission. We provide a unique partnership model to university research ...
Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment. To achieve this goal, we assembled a purpose-driven team, recruiting pioneers in oncology, gene therapy, cell therapy and gene editing to join our mission. We provide a unique partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2450 Perimeter Park Dr #200 Morrisville, NC 27560
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Inceptor Bio Names Matthias Schroff CEO
Inceptor Bio Names Matthias Schroff CEO

09 May 2023

// CONTRACT PHARMA

https://www.contractpharma.com/contents/view_breaking-news/2023-05-09/inceptor-bio-names-matthias-schroff-ceo/?widget=listSection

CONTRACT PHARMA
09 May 2023

https://www.pharmaceutical-technology.com/news/inceptor-bio-avectas-car-t-cell/

PHARMACEUTICAL-TECHNOLOGY
13 Oct 2022
Inceptor Bio to use $37M series A to nudge CAR-T into clinic
Inceptor Bio to use $37M series A to nudge CAR-T into clinic

19 May 2022

// James Waldron FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/inceptor-bio-uses-37m-series-nudge-car-t-program-clinic-establish-manufacturing-base

James Waldron FIERCEBIOTECH
19 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty